Varian Medical Systems (VAR) Shares are Up 2.39%

Varian Medical Systems (VAR) : Traders are bullish on Varian Medical Systems (VAR) as it has outperformed the S&P 500 by a wide margin of 3.49% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 1.85%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 2.39% in the last 1 week, and is up 1.4% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The stock has recorded a 20-day Moving Average of 0.41% and the 50-Day Moving Average is 3.61%.The 200 Day SMA reached 15.16% Varian Medical Systems, Inc. is up 18.33% in the last 3-month period. Year-to-Date the stock performance stands at 18.65%.


Varian Medical Systems (VAR) : The consensus price target for Varian Medical Systems (VAR) is $93.4 for the short term with a standard deviation of $6.47. The most optimist securities analyst among the 5 who monitor the stock believes that the stock can reach $102, however, the pessimist price target for the company is $86.

Company shares have received an average consensus rating of Hold for the current week Varian Medical Systems (NYSE:VAR): stock was range-bound between the intraday low of $95.49 and the intraday high of $96.36 after having opened at $96.08 on Fridays session. The stock finally closed in the red at $96.08, a loss of -0.29%. The stock remained in the red for the whole trading day. The total traded volume was 1,018,620 shares. The stock failed to cross $96.36 in Fridays trading. The stocks closing price on Thursday was $95.87.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.